World Health Organization. (2025) HIV and AIDS. World Health Organization.
External website: https://www.who.int/news-room/fact-sheets/detail/h...
Key facts:
- HIV remains a major global public health issue, having claimed an estimated 44.1 million lives to date. Transmission is ongoing in all countries globally.
- There were an estimated 40.8 million people living with HIV at the end of 2024, 65% of whom are in the WHO African Region.
- In 2024, an estimated 630 000 people died from HIV-related causes and an estimated 1.3 million people acquired HIV.
- There is no cure for HIV infection. However, with access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.
- WHO, the Global Fund and UNAIDS all have global HIV strategies that are aligned with the SDG target 3.3 of ending the HIV epidemic by 2030.
- By 2025, 95% of all people living with HIV should have a diagnosis, 95% of whom should be taking lifesaving antiretroviral treatment, and 95% of people living with HIV on treatment should achieve a suppressed viral load for the benefit of the person’s health and for reducing onward HIV transmission. In 2024, these percentages were 87%, 89%, and 94% respectively.
- In 2024, of all people living with HIV, 87% knew their status, 77% were receiving antiretroviral therapy and 73% had suppressed viral loads.
Item Type
FactSheet
Publication Type
International
Drug Type
Opioid
Intervention Type
Harm reduction
Date
July 2025
Publisher
World Health Organization
Corporate Creators
World Health Organization
EndNote
Accession Number
HRB (Electronic Only)
Subjects
B Substances > Substances in general
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Acquired immunodeficiency syndrome (AIDS)
J Health care, prevention, harm reduction and treatment > Risk and protective factors > Risk factors
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > International
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Acquired immunodeficiency syndrome (AIDS)
J Health care, prevention, harm reduction and treatment > Risk and protective factors > Risk factors
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > International
Repository Staff Only: item control page